Destination Wealth Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-500
Closed -$3K 556
2019
Q2
$3K Buy
+500
New +$3K ﹤0.01% 525